D'Ambrosio Anthony L, Bruce Jeffrey N
Department of Neurological Surgery, Neurological Institute of New York, 710 West 168th Street, New York, NY 10032, USA.
Curr Neurol Neurosci Rep. 2003 May;3(3):206-14. doi: 10.1007/s11910-003-0080-3.
Aggressive surgical resection continues to be the mainstay of current meningioma management, with advances in microsurgical techniques facilitating the safety and effectiveness of this approach. Complete surgical removal of meningiomas provides the optimal opportunity for long-term remission. Advances in skull base surgical approaches have greatly improved patient outcomes for tumors in precarious locations once thought to be inoperable. For tumors that recur or are unresectable, stereotactic radiosurgery and conformal fractionated radiation therapy can provide safe, palliative treatment with favorable long-term outcomes. Additionally, advances in the understanding of molecular biologic and biochemical mechanisms underlying meningioma growth offer unique opportunities for potential treatment adjuncts for atypical and malignant tumors. This review discusses current understanding of meningioma pathology and accepted meningioma treatment paradigms. The technologic advances and experimental strategies for the future treatment of complex intracranial meningiomas are also discussed.
积极的手术切除仍然是当前脑膜瘤治疗的主要手段,显微外科技术的进步提高了这种治疗方法的安全性和有效性。完整手术切除脑膜瘤为长期缓解提供了最佳机会。颅底手术方法的进步极大地改善了曾被认为无法手术的危险部位肿瘤患者的预后。对于复发或无法切除的肿瘤,立体定向放射外科和适形分割放射治疗可提供安全的姑息治疗,并取得良好的长期效果。此外,对脑膜瘤生长的分子生物学和生化机制认识的进展为非典型和恶性肿瘤的潜在辅助治疗提供了独特机会。本文综述了目前对脑膜瘤病理学的认识以及公认的脑膜瘤治疗模式。还讨论了未来治疗复杂颅内脑膜瘤的技术进步和实验策略。